Leslie Ann Robinson

Title: Innovations of Leslie Ann Robinson

Introduction

Leslie Ann Robinson is a prominent inventor based in Del Mar, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for various medical applications. With a total of three patents to her name, Robinson's work has the potential to impact the treatment of several diseases.

Latest Patents

Robinson's latest patents include innovative compounds that serve as modulators of the glucocorticoid receptor. These non-steroidal compounds are designed to treat diseases that require glucocorticoid receptor agonist or antagonist therapy, such as obesity, diabetes, and inflammatory disorders. Another notable patent involves tetrahydroquinoline derivatives, which act as antithrombotic agents. This invention focuses on tetracyclic tetrahydroquinoline compounds that selectively inhibit serine protease enzymes, particularly factor VIIa, and can be used as anticoagulant agents.

Career Highlights

Throughout her career, Robinson has worked with leading pharmaceutical companies, including Bristol-Myers Squibb and Novartis. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.

Collaborations

Robinson has collaborated with notable professionals in her field, including Jinglan Zhou and Nikolaus M. Gubernator. These partnerships have further enhanced her research and development efforts.

Conclusion

Leslie Ann Robinson's contributions to the pharmaceutical industry through her innovative patents demonstrate her commitment to improving healthcare. Her work continues to pave the way for new treatments and therapies that can benefit patients worldwide.